Assessment of antiarrhythmic drugs in experimental pharmacology
Caillard, C.G.; Louis, J.C.
Methods and Findings in Experimental and Clinical Pharmacology 2(5): 223-252
1980
ISSN/ISBN: 0379-0355 PMID: 6765586 Document Number: 160353
Document emailed within 1 workday
Related Documents
Roden, D.M. 1985: Antiarrhythmic drugs. Clinical pharmacology of the old and the new agents Postgraduate Medicine 78(4): 28-37Singh, B.N.; Cho, Y.W.; Kuemmerle, H.P. 1981: Clinical pharmacology of antiarrhythmic drugs: a review and overview, part Ii International Journal of Clinical Pharmacology Therapy and Toxicology 19(5): 185-199
Follath, F. 1991: Clinical pharmacology of antiarrhythmic drugs: variability of metabolism and dose requirements Journal of Cardiovascular Pharmacology 17(Suppl 6): S74-S76
Ernest, K. 1975: Pharmacology of new ethylenediamine derivatives (ROM-126, ROM-131, MK-142) with antiarrhythmic action. Part II. Antiarrhythmic properties, the influence on heart and some hemodynamic parameters Polish Journal of Pharmacology and Pharmacy 27(4): 381-398
Nawada, T.; Tanaka, Y.; Hirai, S.; Hisatome, I.; Hasegawa, J.; Kotake, H.; Mashiba, H. 1994: Evaluation of negative inotropic and antiarrhythmic effects of class 1 antiarrhythmic drugs International Journal of Clinical Pharmacology and Therapeutics 32(7): 347-355
Jacotot, B. 1979: Biochemical and experimental aspects of the lipid-lowering drugs pharmacology La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 55(41-42): 1947-1955
Usuda, K.; Ikeda, T. 1991: Drug induced arrhythmias (digitalis, antiarrhythmic drugs and other drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 49(11): 2666-2671
Matsnev, E.I.; Bodo, D. 1984: Experimental assessment of selected antimotion drugs Aviation Space and Environmental Medicine 55(4): 281-286
Horgan, J.H.; Teo, K.K.; Harte, M. 1982: Modern drugs treatment--No. 11. Antiarrhythmic drugs Irish Medical Journal 75(11): 426-427; 429-432
Yanaginuma, T. 1984: Clinical pharmacology for midwives. 3. Pregnancy and drugs. 3. Drugs with their risk superseding the benefits Josanpu Zasshi 38(6): 526-530
Handwerker, H.O. 1991: Assessment of the effect of ibuprofen and other non-steroidal anti-rheumatic drugs in experimental algesimetry Zeitschrift für Rheumatologie 50(Suppl 1): 15-18
Ignat'ev, M.V. 1975: Some new antiarrhythmic drugs Voenno-Meditsinskii Zhurnal 1: 73-74
Coumel, P.; Thomas, O. 1997: Antiarrhythmic drugs: how to use and to evaluate them Le Journal Medical Libanais. Lebanese Medical Journal 45(4): 221-223
Hoffman, B.F. 1997: Arrhythmias and antiarrhythmic drugs Mount Sinai Journal of Medicine new York 64(2): 136-141
Kock-Weser, J. 1975: Pharmacokinetics of antiarrhythmic drugs Cardiovascular Clinics 7(2): 191-202
Mehta, D.; Saxena, A. 1990: Safety of use of antiarrhythmic drugs Indian Heart Journal 42(6): 445-450
Reiffel, J.A. 2001: Issues in the use of generic antiarrhythmic drugs Current Opinion in Cardiology 16(1): 23-29
Harrison, D.C.; Irwin, W.G. 1981: New concepts for antiarrhythmic drugs in the 1980's Archives des Maladies du Coeur et des Vaisseaux 74(Special Issue): 73-77
Goldberg, P.B.; Stoner, S.A.; Roberts, J. 1978: Influence of age on activity of antiarrhythmic drugs in rat heart Advances in Experimental Medicine and Biology 97: 309-313
Yamashita, T.; Sugimoto, T. 1991: Medical management of arrhythmias; newer antiarrhythmic drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 49(11): 2680-2686